Cargando…
Physician Attitudes towards Pharmacological Cognitive Enhancement: Safety Concerns Are Paramount
The ethical dimensions of pharmacological cognitive enhancement have been widely discussed in academic circles and the popular media, but missing from the conversation have been the perspectives of physicians - key decision makers in the adoption of new technologies into medical practice. We queried...
Autores principales: | Banjo, Opeyemi C., Nadler, Roland, Reiner, Peter B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001858/ https://www.ncbi.nlm.nih.gov/pubmed/21179461 http://dx.doi.org/10.1371/journal.pone.0014322 |
Ejemplares similares
-
The Paramount story /
por: Eames, John Douglas -
Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany
por: Franke, Andreas G, et al.
Publicado: (2014) -
ALDO-DHF & Paramount
por: ElGuindy, Ahmed M
Publicado: (2013) -
Attitudes toward pharmacological cognitive enhancement—a review
por: Schelle, Kimberly J., et al.
Publicado: (2014) -
Swiss University Students’ Attitudes toward Pharmacological Cognitive Enhancement
por: Maier, Larissa J., et al.
Publicado: (2015)